Valproic Acid Oral Syrup Clinical Trials

• Valproic Acid-Based 2-Agent Oral Regimens for Patients With Advanced Solid Tumor
  ClinicalTrials.gov Identifier: NCT00495872 - Recruiting
  Advanced Cancer
  
• Randomized Phase Iii-Study On Valproic Acid In Combination With All-Trans Retinoic Acid, Standard Induction- And Consolidation Therapy In Older Patients With Newly Diagnosed Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00151255 - Recruiting
  Acute myeloid leukemia, age > 60 years
  
• Randomized Phase Ii-Study On Valproic Acid, All-Trans Retinoic Acid And Their Combination In Induction And Consolidation Therapy As Well As Pegfilgrastim After Consolidation Therapy In Younger Patients With Newly Diagnosed Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00151242 - Recruiting
  Acute Myeloid Leukemia
  
• Valproic Acid in Treating Patients With Kaposi's Sarcoma
  ClinicalTrials.gov Identifier: NCT00075777 - Active, not recruiting
  recurrent Kaposi's sarcoma; epidemic Kaposi's sarcoma
  
• Valproic Acid in Treating Young Patients With Recurrent or Refractory Solid Tumors or CNS Tumors
  ClinicalTrials.gov Identifier: NCT00107458 - Active, not recruiting
  childhood brain tumor; childhood meningioma; childhood solid tumor; childhood spinal cord tumors
  
• PhII 5-Azacytidine Plus Valproic Acid and Eventually Atra in Intermediate II and High Risk MDS
  ClinicalTrials.gov Identifier: NCT00439673 - Active, not recruiting
  Myelodysplastic Syndromes
  
• Decitabine and Valproic Acid in Treating Patients With Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00084981 - Active, not recruiting
  recurrent non-small cell lung cancer; stage IV non-small cell lung cancer
  
• Azacytidine With Valproic Acid Versus Ara-C in AML/MDS Patients
  ClinicalTrials.gov Identifier: NCT00382590 - Active, not recruiting
  Acute Myelogenous Leukemia; Myelodysplastic Syndrome; Leukemia
  
• Phase I Trial of Valproic Acid and Epirubicin in Solid Tumor Malignancies
  ClinicalTrials.gov Identifier: NCT00246103 - Recruiting
  Neoplams, Advanced
  
• The Effects of Valproic Acid on Zidovudine Glucuronidation and Pharmacokinetics in HIV-Infected Patients.
  ClinicalTrials.gov Identifier: NCT00000629 - Completed
  HIV Infections
  
• Decitabine With or Without Valproic Acid in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00109824 - Recruiting
  recurrent adult Burkitt's lymphoma; recurrent adult diffuse large cell lymphoma; recurrent mantle cell lymphoma
  
• Comparing Compliance, Tolerability, Efficacy and Adverse Events in Bipolar Tients From Valproic Acid to Depakote ER.
  ClinicalTrials.gov Identifier: NCT00211250 - Recruiting
  Mood Disorder
  
• Valproic Acid, Temozolomide, and Radiation Therapy in Treating Patients With Glioblastoma Multiforme
  ClinicalTrials.gov Identifier: NCT00313664 - Recruiting
  Brain and Central Nervous System Tumors
  
• Decitabine and Valproic Acid in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
  ClinicalTrials.gov Identifier: NCT00079378 - Recruiting
  adult acute myeloid leukemia; refractory chronic lymphocytic leukemia; Small Lymphocytic Lymphoma
  
• Study of Valproic Acid to Treat HIV Infected Adults
  ClinicalTrials.gov Identifier: NCT00312546 - Recruiting
  HIV Infections
  
• Phase I/II Trial of Valproic Acid and Karenitecin for Melanoma
  ClinicalTrials.gov Identifier: NCT00358319 - Recruiting
  Malignant Melanoma
  
• Valproic Acid and Its Effects on HIV Latent Reservoirs
  ClinicalTrials.gov Identifier: NCT00289952 - Recruiting
  HIV Infections
  
• Valproic Acid (Depakote ER) in Patients With Advanced Thyroid Cancer
  ClinicalTrials.gov Identifier: NCT00525135 - Recruiting
  Head and Neck Cancer
  
• Azacytidine and Valproic Acid in Patients With Advanced Cancers
  ClinicalTrials.gov Identifier: NCT00496444 - Active, not recruiting
  Advanced Cancers
  
• A study to compare the efficacy of intravenous loading doses followed by maintenance treatment with oral ibandronic acid versus zoledronic acid in patients with skeletal metastases experiencing moderate to severe pain.
  ClinicalTrials.gov Identifier: NCT00099177 - Active, not recruiting
  Pain; Bone Neoplasms; Neoplasm Metastasis
  
• Phase II Study of Valproic Acid With FEC100 for Patients With Locally Advanced Breast Cancer
  ClinicalTrials.gov Identifier: NCT00437801 - Recruiting
  Breast Cancer
  
• Phase I Study of Temazolomide, Valproic Acid and Radiation Therapy in Subjects With Brain Metastases
  ClinicalTrials.gov Identifier: NCT00437957 - Recruiting
  Unresectable Brain Metastases
  
• Valproic Acid in the Induction of EBV Lytic Cycle Antigen Expression in Nasopharyngeal Carcinoma
  ClinicalTrials.gov Identifier: NCT00181220 - Recruiting
  Nasopharyngeal Carcinoma
  
• Valproic Acid and Carnitine in Patients With Spinal Muscular Atrophy
  ClinicalTrials.gov Identifier: NCT00227266 - Active, not recruiting
  Spinal Muscular Atrophy
  
• 5-Azacytidine Valproic Acid and ATRA in AML and High Risk MDS
  ClinicalTrials.gov Identifier: NCT00339196 - Recruiting
  Acute Myelogenous Leukaemia (AML); Myelodysplastic Syndrome (MDS)
  
• Azacitidine and Valproic Acid Plus Carboplatin in Patients With Platinum Resistant Epithelial Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00529022 - Recruiting
  Advanced Cancer; Ovarian Cancer
  
• Valproic Acid and Bevacizumab in Patients With Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00530907 - Recruiting
  Advanced Cancer
  
• A study to assess the efficacy and safety of 100 mg and 150 mg monthly oral ibandronate in women with postmenopausal osteoporosis having completed the phase III oral ibandronate trial
  ClinicalTrials.gov Identifier: NCT00081653 - Active, not recruiting
  Osteoporosis
  
• Randomized Placebo-Controlled Trial of Valproic Acid in Patients With Progressive Supranuclear Palsy
  ClinicalTrials.gov Identifier: NCT00385710 - Recruiting
  Progressive Supranuclear Palsy (PSP)
  
• A Study of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients with Solid Tumors
  ClinicalTrials.gov Identifier: NCT00127127 - Active, not recruiting
  Tumors
  
• Valproic Acid in Ambulant Adults With Spinal Muscular Atrophy
  ClinicalTrials.gov Identifier: NCT00481013 - Recruiting
  Spinal Muscular Atrophy
  
• Compliance With Once-Daily Divalproex Extended-Release Tablets (Depakote-ER) Versus Multiple-Daily Dose Valproic Acid Capsules (Depakene) in Epilepsy:
  ClinicalTrials.gov Identifier: NCT00356018 - Not yet recruiting
  Epilepsy
  
• Childhood Absence Epilepsy Rx PK-PD-Pharmacogenetics Study
  ClinicalTrials.gov Identifier: NCT00088452 - Active, not recruiting
  Childhood Absence Epilepsy; Petit Mal Epilepsy; Epilepsy; Seizures
  
• A Study of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Solid Tumors
  ClinicalTrials.gov Identifier: NCT00373490 - Active, not recruiting
  Tumors
  
• A Study of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients with Malignant Lymphoma
  ClinicalTrials.gov Identifier: NCT00127140 - Active, not recruiting
  Malignant Lymphoma
  
• HDAC Inhibitor Valproic Acid as an Effective Therapy for Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00524667 - Not yet recruiting
  Chronic Lymphocytic Leukemia
  
• Optical Sensor for Photodynamic Detection of Oral Pathology
  ClinicalTrials.gov Identifier: NCT00540774 - Enrolling by invitation
  Oral Diseaes; Abnormal Oral Mucosa
  
• Photodynamic Therapy Using Aminolevulinic Acid in Treating Patients With Oral Leukoplakia
  ClinicalTrials.gov Identifier: NCT00571558 - Recruiting
  Head and Neck Cancer; Precancerous/Nonmalignant Condition
  
• Pilot Study on the Effect of Oral Controlled-Release Alpha-Lipoic Acid on Oxidative Stress in Adolescents With Type 1 Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00187564 - Active, not recruiting
  Diabetes Mellitus, Type 1
  
• Phase I/II Study of Decitabine and Valproic Acid in Relapsed/Refractory Leukemia or Myelodysplastic Syndromes
  ClinicalTrials.gov Identifier: NCT00075010 - Terminated
  Leukemia; Myelodysplastic Syndromes
  
• Activity of Essential Fatty Acid Elongation/Desaturation Pathway During Early Life in Human Infants, In Vivo
  ClinicalTrials.gov Identifier: NCT00342303 - Active, not recruiting
  Fatty Acid Metabolism
  
• High Dose Oral 4-Aminosalicylic Acid (PASER®) to Control Acute Flares of Mild to Moderate Crohn's Disease
  ClinicalTrials.gov Identifier: NCT00417690 - Recruiting
  Crohn’s Disease
  
• A study to compare the efficacy of intravenous loading doses followed by maintenance treatment with intravenous ibandronic acid versus zoledronic acid in patients with skeletal metastases experiencing moderate to severe pain.
  ClinicalTrials.gov Identifier: NCT00099203 - Active, not recruiting
  Pain; Bone Neoplasms; Neoplasm Metastasis
  
• Relationship Between Folic Acid and Warfarin Metabolism and Effect
  ClinicalTrials.gov Identifier: NCT00162409 - Recruiting
  Folic Acid Deficiency
  
• Oral Health Education Program
  ClinicalTrials.gov Identifier: NCT00103493 - Active, not recruiting
  Dental Caries; Oral hygiene; Oral health; Dental health
  
• Pioglitazone in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia
  ClinicalTrials.gov Identifier: NCT00099021 - Active, not recruiting
  lip and oral cavity cancer; Oropharyngeal Cancer; Oral Leukoplakia
  
• Compare Efficacy of Gastric Acid Suppression by Oral and Intravenous Administration of Esomeprazole in Patients With Peptic Ulcer
  ClinicalTrials.gov Identifier: NCT00471029 - Recruiting
  Peptic Ulcer
  
• High Dose Oral 4-Aminosalicylic Acid (PASER®) to Control Acute Flares of Mild to Moderate Crohn's Disease in Children
  ClinicalTrials.gov Identifier: NCT00495521 - Recruiting
  Crohn's Disease
  
• DHA (Docosahexaenoic Acid), an Omega 3 Fatty Acid, in Slowing the Progression of Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00440050 - Active, not recruiting
  Alzheimer's Disease
  
• Double-Blind Extension of HORIZON Pivotal Fracture Trial (Zoledronic Acid in the Treatment of Postmenopausal Osteoporosis)
  ClinicalTrials.gov Identifier: NCT00145327 - Active, not recruiting
  Osteoporosis
  
• Folic Acid and Omega -3 Fatty Acid Supplementation in Depressed Older Adults
  ClinicalTrials.gov Identifier: NCT00480207 - Recruiting
  Depression
  
• Fenretinide in Treating Patients with Neoplasia of the Mouth
  ClinicalTrials.gov Identifier: NCT00003223 - Active, not recruiting
  lip and oral cavity cancer; prevention of oral cancer
  
• Celecoxib in Treating Patients With Precancerous Lesions of the Mouth
  ClinicalTrials.gov Identifier: NCT00014404 - Active, not recruiting
  lip and oral cavity cancer; prevention of oral cancer
  
• On-Demand Use of Pantoprazole: Determinants for Chronic Use of Acid Suppressive Medication
  ClinicalTrials.gov Identifier: NCT00161096 - Active, not recruiting
  Chronic Use of Acid Suppressive Medication; GORD; GERD; Reflux; Peptic Ulcer
  
• Wild Type p53 Adenovirus for Oral Premalignancies
  ClinicalTrials.gov Identifier: NCT00410865 - Active, not recruiting
  Mouth Cancer; Dysplasia/Carcinoma in Situ (CIS) of the Oral Cavity; Dysplasia/Carcinoma in Situ (CIS) of the Oral Pharynx
  
• Valproic Acid Sodium Salt in Bipolar Disorder
  ClinicalTrials.gov Identifier: NCT00431522 - Completed
  Bipolar Disorder
  
• Safety and Efficiency Study of Valproic Acid In HAM/TSP
  ClinicalTrials.gov Identifier: NCT00519181 - Terminated
  HTLV-I-Associated Myelopathy
  
• Assess Platelet Function and Safety Following Administration of IV Diclofenac Sodium, Oral Diclofenac Potassium, IV Ketorolac Tromethamine, and Acetylsalicylic Acid in Healthy Adult Male Volunteers
  ClinicalTrials.gov Identifier: NCT00548678 - Recruiting
  Healthy
  
• Oral acyclovir for neonatal HSV disease of the skin,eyes and mouth
  ClinicalTrials.gov Identifier: NCT00031447 - Active, not recruiting
  Herpes Simplex
  
• Assessment of oral acyclovir in neonates with HSV involving the CNS
  ClinicalTrials.gov Identifier: NCT00031460 - Active, not recruiting
  Herpes Simplex
  
• Oral Mucositis in Patients Receiving Radiation Therapy for Cancer of the Mouth, Pharynx, or Larynx
  ClinicalTrials.gov Identifier: NCT00004234 - Active, not recruiting
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Nasopharyngeal Cancer; oral complications of cancer and cancer therapy; ...
  
• Study of Safety and Dosing Effect on SMN Levels of Valproic Acid (VPA) in Patients With Spinal Muscular Atrophy
  ClinicalTrials.gov Identifier: NCT00374075 - Completed
  Spinal Muscular Atrophy
  
• Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00045006 - Active, not recruiting
  Cancer
  
• Oral Estramustine and Oral Vinorelbine in the Treatment of Hormone-Refractory Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00151086 - Active, not recruiting
  Prostate Cancer
  
• Expression of Hypoxia-Inducible Factor-α in Oral Precancers and Cancers
  ClinicalTrials.gov Identifier: NCT00154973 - Recruiting
  Oral Cancer
  
• Prevention of Oral Malodor With an Oral Sticker Containing Herbal Formula
  ClinicalTrials.gov Identifier: NCT00250289 - Recruiting
  Halitosis; Oral Malodor; Bad Breath
  
• A Study of the Clinical Safety, Tolerability, and Efficacy of Zoledronic Acid Compared to an Oral Bisphosphonate
  ClinicalTrials.gov Identifier: NCT00100555 - Completed
  Osteoporosis
  
• Feasibility of Retinoic Acid Treatment in Emphysema (FORTE)
  ClinicalTrials.gov Identifier: NCT00000621 - Active, not recruiting
  Emphysema; Lung Diseases; Lung Diseases, Obstructive; Chronic Obstructive Pulmonary Disease
  
• Effect of Polyunsaturated Fatty Acids on Cardiovascular and Motor Responses Under Stress
  ClinicalTrials.gov Identifier: NCT00014027 - Recruiting
  Healthy
  
• Influence of an Oral Nutritional Supplement Rich in Omega-3 Fatty Acids on Functional State and Quality of Life in Malnourished Patients with Gastroenterological Tumors
  ClinicalTrials.gov Identifier: NCT00168987 - Not yet recruiting
  Colorectal Neoplasms; Hepatocellular Carcinoma; Cholangiocarcinoma
  
• Efficacy and Safety of Zoledronic Acid in the Prevention of Bone Loss in Postmenopausal Women with Osteopenia, 45 Years of Age and Older.
  ClinicalTrials.gov Identifier: NCT00132808 - Active, not recruiting
  Osteopenia (osteoporosis prevention)
  
• Comparison of the Gastric Acid Suppressive Effects of Esomeprazole and Generic Omeprazole
  ClinicalTrials.gov Identifier: NCT00542347 - Recruiting
  Gastric Acid
  
• A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
  ClinicalTrials.gov Identifier: NCT00323518 - Active, not recruiting
  Oral Mucositis; Stomatitis
  
• A Pharmacokinetic Study to Compare the Dosing of Valproic Acid in Subjects With Different Body Weights
  ClinicalTrials.gov Identifier: NCT00298857 - Terminated
  Healthy; Obesity; Pharmacokinetics
  
• Smoking Status and Body Image in Oral Cancer Patients
  ClinicalTrials.gov Identifier: NCT00412490 - Active, not recruiting
  Oral Cavity Cancer
  
• Dentures and Dental Implants in Treating Patients Undergoing Surgery for Mouth Cancer
  ClinicalTrials.gov Identifier: NCT00006341 - Active, not recruiting
  oral complications of cancer and cancer therapy; stage III lip and oral cavity cancer; stage II lip and oral cavity cancer; Quality of Life; ...
  
• The Effect of Folic Acid on Efficacy of Sulfadoxine-Pyrimethamine in Pregnant Women in Western Kenya
  ClinicalTrials.gov Identifier: NCT00130065 - Active, not recruiting
  Malaria
  
• Laser Therapy in Preventing Oral Mucositis in Patients Undergoing Bone Marrow Transplantation
  ClinicalTrials.gov Identifier: NCT00024037 - Active, not recruiting
  oral complications of cancer and cancer therapy
  
• Controlled Trial of 4-Aminosalicylic Acid in Patients with Small Bowel Crohn's Disease
  ClinicalTrials.gov Identifier: NCT00004423 - Active, not recruiting
  Crohn's Disease
  
• Study of Docosahexaenoic Acid (DHA) Supplementation in Patients with X-Linked Retinitis Pigmentosa
  ClinicalTrials.gov Identifier: NCT00004827 - Active, not recruiting
  Retinitis Pigmentosa
  
• Surgery and Radiation Therapy With or Without Chemotherapy in Treating Patients With Mouth Cancer
  ClinicalTrials.gov Identifier: NCT00002747 - Active, not recruiting
  stage IV squamous cell carcinoma of the lip and oral cavity; stage II squamous cell carcinoma of the lip and oral cavity; ...
  
• An Investigational Drug Study with Suberoylanilide Hydroxamic Acid in Relapsed Diffuse Large B-cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00097929 - Active, not recruiting
  B-Cell Lymphoma
  
• Asenapine with Lithium or Valproic Acid for Bipolar Disorder (Information Omitted Due to Their Commercial Sensitivity)
  ClinicalTrials.gov Identifier: NCT00145470 - Completed
  Bipolar Disorder
  
• Study of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Combination with Bortezomib in Patients with Advanced Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00111813 - Recruiting
  Multiple Myeloma
  
• Diagnostic Trial in Patients Who Are Undergoing Surgery for Early Stage Mouth Cancer
  ClinicalTrials.gov Identifier: NCT00042926 - Active, not recruiting
  stage I squamous cell carcinoma of the lip and oral cavity; stage II squamous cell carcinoma of the lip and oral cavity
  
• Safety and Efficacy Trial with Zoledronic Acid for the Treatment of Paget's Disease of Bone
  ClinicalTrials.gov Identifier: NCT00103740 - Active, not recruiting
  Paget's Disease of Bone
  
• Pilocarpine in Preventing Mucositis and Dry Mouth in Patients Receiving Radiation Therapy for Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00003139 - Active, not recruiting
  oral complications of cancer and cancer therapy; oropharyngeal squamous cell carcinoma; lip and oral cavity squamous cell carcinoma
  
• Switching Osteoporosis Patients Currently on Oral Bisphosphonate to Zoledronic Acid
  ClinicalTrials.gov Identifier: NCT00097812 - Completed
  Osteoporosis
  
• Randomized Study of Tauroursodeoxycholic Acid in Prophylactic Therapy of Total Parenteral Nutrition Associated Cholestasis in Infants
  ClinicalTrials.gov Identifier: NCT00004410 - Recruiting
  Cholestasis
  
• Iseganan Hydrochloride in Preventing Oral Mucositis in Patients Who Are Undergoing Radiation Therapy for Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00022373 - Active, not recruiting
  Salivary Gland Cancer; lip and oral cavity cancer; Head and Neck Cancer; Oropharyngeal Cancer
  
• Suberoylanilide Hydroxamic Acid in Treating Patients With Relapsed Non-Hodgkin''s Lymphoma
  ClinicalTrials.gov Identifier: NCT00124631 - Active, not recruiting
  recurrent adult diffuse large cell lymphoma
  
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients with Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00006051 - Active, not recruiting
  Throat Cancer; Oral Cancer
  
• Glutamine in Treating Mucositis Caused by Radiation Therapy in Patients With Newly Diagnosed Cancer of the Mouth or Throat
  ClinicalTrials.gov Identifier: NCT00006994 - Active, not recruiting
  lip and oral cavity cancer; oral complications of chemotherapy and head and neck radiation; Oropharyngeal Cancer; Pain; radiation toxicity
  
• A Peri-Intubation Oral Intervention to Reduce Oral Flora and VAP
  ClinicalTrials.gov Identifier: NCT00248300 - Recruiting
  Pneumonia
  
• Effects of Oral Care in the Neuroscience ICU
  ClinicalTrials.gov Identifier: NCT00518752 - Recruiting
  Ventilator Associated Pneumonia; Oral Hygiene
  
• Fluorescence & Reflectance Imaging to Detect Oral Neoplasia
  ClinicalTrials.gov Identifier: NCT00542373 - Recruiting
  Oral Cancer
  
• Oral Budesonide vs. Oral Mesalazine in Active CD
  ClinicalTrials.gov Identifier: NCT00300118 - Recruiting
  Crohn's Disease
  
• Efficacy and Safety Study for an Oral Contraceptive Containing Folate
  ClinicalTrials.gov Identifier: NCT00468481 - Recruiting
  Oral Contraception
  
• Intraoral Grafting of Ex Vivo Produced Oral Mucosal Composites
  ClinicalTrials.gov Identifier: NCT00000111 - Active, not recruiting
  Mouth Diseases
  
• A Randomized Study of Sulindac in Oral Premalignant Lesions
  ClinicalTrials.gov Identifier: NCT00299195 - Recruiting
  Leukoplakia, Oral; Benign Neoplasms